Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 study evaluating IMG-007 in adults with atopic dermatitis was terminated, with results posted for safety, pharmacokinetics, and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• IMG-007

Snippet

Sponsor: Inmagene LLC | Conditions: Atopic Dermatitis, Moderate-to-severe Atopic Dermatitis | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-11-06